Neurapas Balance (Dry Extract Of St. John's Wort (4,6-6,5:1), Extraction Solvent: Ethanol 38% M/M, Dry Extract Of Vale)

The extract contains bioactive compounds such as hypericin and hyperforin. These constituents influence neurotransmitter pathways by inhibiting the reuptake of serotonin, dopamine and norepinephrine, and by modulating ion channels. The resulting effect is an increase in the availability of these neurotransmitters in the brain, which may help improve mood and emotional stability.

The appropriate dose of Neurapas Balance is determined by the prescribing clinician based on the individual’s condition, age, weight and concomitant therapies. Because dosing can vary, patients should follow the specific instructions provided by their healthcare provider and not adjust the amount without professional advice.

Safety data for St. John's Wort extracts during pregnancy and lactation are limited. Current guidance advises caution and recommends that the product be avoided unless the potential benefit outweighs the possible risk. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss alternatives with their physician.

To place an order, visit the product page on gnhindia.com and submit an enquiry specifying the required quantity of Neurapas Balance. GNH India works with hospitals, pharmacies and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Conventional antidepressants such as SSRIs target serotonin reuptake with a well‑defined pharmacological profile, whereas Neurapas Balance uses a multi‑component herbal extract that modulates several neurotransmitters simultaneously. While St. John's Wort may be suitable for mild cases, it has a higher potential for drug‑drug interactions and variable potency compared with prescription antidepressants, which are typically more rigorously studied.

Neurapas Balance should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability. Do not refrigerate or freeze the supplement.

Neurapas Balance is taken orally. The recommended method is to swallow the prescribed amount with a full glass of water, preferably with food to minimise gastrointestinal discomfort. Patients should not crush or dissolve the tablets (if in tablet form) unless instructed otherwise by a healthcare professional.

The most serious risks include serotonin syndrome when combined with other serotonergic agents, severe photosensitivity leading to sunburn‑like skin reactions, and the possible triggering of manic or hypomanic episodes in individuals with bipolar disorder. Prompt medical attention is required if symptoms such as agitation, rapid heart rate, high fever, or severe skin reactions occur.

Neurapas Balance should be avoided by individuals currently taking monoamine oxidase inhibitors (MAOIs), selective serotonin reuptake inhibitors (SSRIs) or other serotonergic drugs due to the risk of serotonin syndrome. It is also contraindicated in pregnant or breastfeeding women unless a physician determines that the benefit outweighs the risk, and in patients with a history of bipolar disorder who are prone to manic episodes.